Mavroeidi IA

References (2)

Title : (68)Ga-Fibroblast Activation Protein Inhibitor PET\/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy - Lanzafame_2024_J.Nucl.Med_65_880
Author(s) : Lanzafame H , Mavroeidi IA , Pabst KM , Desaulniers M , Ingenwerth M , Hirmas N , Kessler L , Nader M , Bartel T , Leyser S , Barbato F , Schuler M , Bauer S , Siveke JT , Herrmann K , Hamacher R , Fendler WP
Ref : J Nucl Med , 65 :880 , 2024
Abstract :
PubMedSearch : Lanzafame_2024_J.Nucl.Med_65_880
PubMedID: 38724279

Title : Fibroblast Activation Protein alpha-Directed Imaging and Therapy of Solitary Fibrous Tumor - Hamacher_2024_J.Nucl.Med_65_252
Author(s) : Hamacher R , Pabst KM , Cheung PF , Heilig CE , Hullein J , Liffers ST , Borchert S , Costa PF , Schaarschmidt BM , Kessler L , Miera MA , Droste M , Akbulut M , Falkenhorst J , Zarrad F , Kostbade K , Mavroeidi IA , Glimm H , Umutlu L , Schuler M , Hubschmann D , Bauer S , Frohling S , Herrmann K , Siveke JT , Schildhaus HU , Fendler WP
Ref : J Nucl Med , 65 :252 , 2024
Abstract :
PubMedSearch : Hamacher_2024_J.Nucl.Med_65_252
PubMedID: 38176718